Susquehanna Fundamental Investments, LLC Moleculin Biotech, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.23 - $1.9 $24,456 - $37,777	-19,883 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.64 - $2.83 $12,327 - $21,273	-7,517 Reduced 27.43%	19,883 $37,000
Q3 2021 Nov 15, 2021	SELL	$2.7 - $3.59 $10,260 - $13,642	-3,800 Reduced 12.18%	27,400 $82,000
Q2 2021 Aug 11, 2021	SELL	$3.21 - $4.06 $963 - $1,217	-300 Reduced 0.95%	31,200 $115,000
Q1 2021 May 17, 2021	BUY	$3.7 - $6.42 $116,550 - $202,230	31,500 New	31,500 $129,000

3.35K

Ticker MBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,606,700
Market Cap $48.6M
Description
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.